Location History:
- Wolfshausen, DE (2013 - 2018)
- Sart-Tilman, BE (2015 - 2021)
Company Filing History:
4 out of 12 
3 out of 41 
1 out of 103 
Years Active: 2013-2025
Title: Katja Bierau: Innovator in Cancer Detection and Treatment
Introduction
Katja Bierau is a prominent inventor based in Sart-Tilman, Belgium. She has made significant contributions to the field of cancer detection and treatment, holding a total of 8 patents. Her work focuses on innovative methods for identifying epigenetic modifications that can indicate a predisposition to cancer.
Latest Patents
Katja Bierau's latest patents include compositions for detecting epigenetic modifications. One of her notable inventions involves a method for detecting a predisposition to cancer by identifying epigenetic changes in specific genes. These genes include members of the NDRG4/NDRG2 subfamily, GATA4, OSMR, GATA5, SFRP1, ADAM23, JPH3, SFRP2, APC, MGMT, TFPI2, BNIP3, FOXE1, SYNE1, SOX17, PHACTR3, and JAM3. The detection of these changes is indicative of a predisposition to cancer. Additionally, her patents describe pharmacogenetic methods for determining suitable treatment regimens for cancer patients, emphasizing the importance of personalized medicine. Her inventions also focus on improved methods for collecting, processing, and analyzing body fluid samples, which can be crucial for diagnosing and characterizing various diseases, particularly gastrointestinal cancers.
Career Highlights
Throughout her career, Katja Bierau has worked with notable companies such as Mdxhealth and Exact Sciences Development Company, LLC. Her experience in these organizations has allowed her to develop and refine her innovative approaches to cancer detection and treatment.
Collaborations
Katja has collaborated with esteemed colleagues, including Manon Van Engeland and Manon Adriaan De Bruine. These partnerships have contributed to her success in advancing cancer research and developing effective diagnostic methods.
Conclusion
Katja Bierau is a trailblazer in the field of cancer detection and treatment, with a strong portfolio of patents that reflect her innovative spirit. Her work continues to impact the medical community and improve patient outcomes.